ClinicalTrials.Veeva

Menu

Conservative Treatment for Atypical Endometrial Hyperplasia and Early Endometrial Cancer

B

Beijing Obstetrics and Gynecology Hospital

Status

Not yet enrolling

Conditions

Atypical Endometrial Hyperplasia and Endometrial Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT06170684
BeijingOGh,

Details and patient eligibility

About

Exploring the efficacy and pregnancy outcomes of conservative treatment for atypical endometrial hyperplasia and endometrial cancer. Study the factors related to predicting treatment efficacy.

Enrollment

100 estimated patients

Sex

Female

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • (1) age ≤ 45 years old, strong desire to preserve reproductive function, and no factors of reproductive dysfunction evaluated before treatment; (2) The pathological type is atypical endometrial hyperplasia or endometrial cancer; (3) Imaging examination confirmed that the tumor was localized to the endometrium; (4) There are follow-up conditions available.

Trial design

100 participants in 2 patient groups

complete remission
non-complete remission

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems